ITEMS IN AFP WITH KEYWORD:
FIT is more sensitive and specific than the older guaiac-based fecal occult blood tests (gFOBTs) when screening for colorectal cancer. We now know that it is also more acceptable to patients and increases uptake in a centrally administered screening program.
Screening for colorectal cancer is recommended in average-risk adults 50 to 75 years of age. Several methods are available, with different benefits, harms, burdens, and costs. Review the options for stool-based screening tests and direct visualization tests, as well as the most effective prevention strategies.
Colorectal cancer has a five-year survival rate of 65%, and family physicians are likely to encounter colorectal cancer survivors in their practice. Learn about the latest guidelines from the American Cancer Society on surveillance, health promotion, screening for other malignancies, and management of treatment effects in these patients.
Persons at increased risk of colorectal cancer should undergo more frequent screening than the general population. Find out recommended screening methods, starting ages, and screening intervals for high-risk individuals.
A 50-year-old woman presents for a routine visit. She is healthy with no significant medical history, takes no medications, and has no personal or family history of cancer.
May 15, 2017 Issue
Should Screening Techniques for Colorectal Cancer All Have an 'A' Recommendation? No: When It Comes to Colorectal Cancer Screening, Test Choice Matters [Editorials: Controversies in Family Medicine]
The AAFP will continue to evaluate different screening tests as more research becomes available, but currently can endorse only those options that have the strongest evidence that benefits exceed harms.
May 15, 2017 Issue
Should Screening Techniques for Colorectal Cancer All Have an 'A' Recommendation? Yes: All Conventional Screening Techniques Should Have an 'A' Recommendation [Editorials: Controversies in Family Medicine]
We need to emphasize the message that regardless of which test is used, patients should get screened for colorectal cancer.
In April 2016, the U.S. Preventive Services Task Force (USPSTF) updated its recommendation on the use of aspirin to prevent cardiovascular disease (CVD). Because emerging evidence suggested that aspirin may also be useful for the prevention of cancer, for the first time, the USPSTF developed a recom...
Feb 15, 2017 Issue
Screening for Colorectal Cancer: Recommendation Statement [U.S. Preventive Services Task Force]
The USPSTF recommends screening for colorectal cancer starting at age 50 years and continuing until age 75 years.
Oct 15, 2016 Issue
Aspirin Use for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer [Putting Prevention into Practice]
S.L. is a 55-year-old man who presents to your office for a routine refill of his antihypertension medication. He also takes a statin and an antidepressant. Although he smokes, his blood pressure and cholesterol are well controlled. His history and physical examination are unremarkable.